Assessment of both virological response at week 4 and at week 12 optimizes prediction of treatment outcome in patients with chronic hepatitis C treated with peginterferon alfa-2b plus ribavirin
HEPATOLOGY(2007)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要